VIBES Integrating virology, artificial intelligence and biophotonics for innovative antiviral strategies against emerging flaviviruses
- Coordinator
- Leibniz-Institut Fuer Photonische Technologien E.v., Germany
- Runs
- 1 January 2027 to 31 December 2030
- Status
- Running
- EU funding
- €4.1m
- Total cost
- —
- Partners
- 24 organisations in 8 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101312032
What the project is doing
In the project's own words, from its summary on CORDIS.
Emerging viral diseases pose a growing threat to global health. Orthoflaviviruses, including dengue, West Nile, and Zika viruses, are of particular concern due to their significant disease burden, complex transmission dynamics and lack of effective interventions. A combination of multiple global changes has already led to increased dengue and West Nile fever incidence in Europe, highlighting the urgent need for innovative approaches to combat these emerging health threats.
VIBES responds to this need with unique interdisciplinary consortium that brings together the rapidly evolving fields of virology, biophotonics, bioinformatics and artificial intelligence, to develop advanced tools and approaches for characterizing host-pathogen interactions and identifying novel antiviral strategies. International partners (including 6 non-academic) from eight countries unite to foster sustainable academic and industrial collaboration.
VIBES will train fourteen doctoral candidates (DCs) in interdisciplinary research aimed at unraveling viral molecular pathomechanisms, identifying and validating new antiviral targets and drugs, and developing innovative bioinformatic tools and powerful biophotonic methods. Each DC will gain hands-on experience in cutting-edge biophotonics, bioinformatics and virology, leveraging complementary tools to drive the project’s scientific objectives.
Individual projects will encompass molecular characterization, target discovery and drug development, in vitro and in vivo validation, and development of cutting-edge antiviral technologies. The network emphasizes high-quality training, career development, and interdisciplinary supervision, equipping the next generation of scientists with the skills to address pressing global health challenges. By bridging academic and industrial expertise in a highly trans-disciplinary approach, VIBES strengthens Europe’s research and innovation capacity, paving the way for impactful solutions to emerging viral threats.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Leibniz-Institut Fuer Photonische Technologien E.v. | Jena | Germany | Coordinator |
| Ustav Fotoniky a Elektroniky Av Cr V.v.i. | Praha 8 | Czechia | Participant |
| Vysoka Skola Chemicko-Technologicka V Praze | Praha | Czechia | Associatedpartner |
| Bundesinstitut Fur Impfstoffe Und Biomedizinische Arzneimittel | Langen | Germany | Associatedpartner |
| Chemometrix GmbH | Wolfersheim | Germany | Participant |
| Friedrich-Schiller-Universität Jena | Jena | Germany | Associatedpartner |
| InfectoGnostics Forschungscampus Jena e.V. | Jena | Germany | Associatedpartner |
| Johann Wolfgang Goethe-Universitaet Frankfurt Am Main | Frankfurt Am Main | Germany | Associatedpartner |
| Leibniz-Institut Fur Virologie | Hamburg | Germany | Participant |
| Universitatsklinikum Jena | Jena | Germany | Participant |
| University of Hamburg | Hamburg | Germany | Associatedpartner |
| openUC2 GmbH | Jena | Germany | Associatedpartner |
| Institut De Recherche Pour Le Developpement | Marseille | France | Participant |
| Institut Pasteur | Paris | France | Participant |
| Universite De Montpellier | Montpellier | France | Associatedpartner |
| Universite Paris Cite | Paris | France | Associatedpartner |
| Urbilateria | Saint Cyr sur Loire | France | Associatedpartner |
| Institut Pasteur Du Cambodge | Phnom Penh | KH | Associatedpartner |
| Universidad Peruana De Ciencias Aplicadas Sac | Lima | PE | Participant |
| Bmd Software Lda | Aveiro | Portugal | Participant |
| Universidade De Aveiro | Aveiro | Portugal | Associatedpartner |
| Universidade De Coimbra | Coimbra | Portugal | Participant |
| Karolinska Institutet | Stockholm | Sweden | Participant |
| Mattek in Vitro Life Science Laboratories Sro | Bratislava | Slovakia | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI